Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients
暂无分享,去创建一个
J. Grinyó | P. Cravedi | J. Martorell. | P. Heeger | O. Bestard | E. Crespo | Marta Jarque | A. Manonelles | E. Melilli | Sergi Luque | M. Gomà | M. Meneghini | C. Donadei | Núria | Cruzado | M. Josep | Lloberas